Skip to main content
. 2021 Aug 23;22(1):99. doi: 10.1186/s10194-021-01310-x

Table 10.

Healthy Life Years (HLYs) potentially gained in 1 year by each element of the proposed intervention (TTH)

Efficacy * uptake Healthy Life Years per capita Luxembourg
N = 124,713
Russia
N = 18,122,512
Spain
N = 10,772,263
Not treated Treated Gained Affected individuals under treatment (n) HLYs gained across population Affected individuals under treatment (n) HLYs gained across population Affected individuals under treatment (n) HLYs gained across population
CURRENT CARE: NO CONSUMER EDUCATION OR HEALTH-CARE PROFESSIONAL TRAINING
 Acute management ASA 1 g or paracetamol 1 g 0.3340 0.0013 0.0009 0.0004 70,890 0.0001 14,833,657 0.00012 4,364,748 0.00011
 Prophylaxis + acute management amitriptyline 100 mg/day + ASA 1 g or paracetamol 1 g 0.3340 0.0013 0.0009 0.0004 0 0.0001 0 0.00012 0 0.00011
Total 70,890 0.0002 14,833,657 0.0026 4,364,748 0.00022
HLYs FOR OVERALL POPULATION 112 23,398 6885
TARGET CARE: WITH CONSUMER EDUCATION AND HEALTH-CARE PROFESSIONAL TRAINING
 Acute management ASA 1 g or paracetamol 1 g 0.4847 0.0013 0.0007 0.0006 96,263 0.0002 20,142,825 0.00017 5,926,950 0.00016
 Prophylaxis + acute management amitriptyline 100 mg/day + ASA 1 g or paracetamol 1 g 0.4886 0.0013 0.0007 0.0006 3188 0.0002 666,981 0.00017 196,257 0.00017
Total 99,451 0.0004 20,809,806 0.0026 6,123,207 0.00033
HLYs FOR OVERALL POPULATION 163 34,090 10,031